Additional value of a triggerlist as selection criterion in identifying patients at high risk of medication-related hospital admission: a retrospective cohort study.


Journal

International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 13 04 2022
accepted: 12 06 2022
pubmed: 18 9 2022
medline: 2 11 2022
entrez: 17 9 2022
Statut: ppublish

Résumé

Of all hospital admissions in older patients, 10-30% seem to be medication-related. However, medication-related admissions are often unidentified in clinical practice. To increase the identification of medication-related hospital admissions in older patients a triggerlist is published in the Dutch guideline for polypharmacy. To assess whether the triggerlist has value as selection criterion to identify patients at high risk of medication-related hospital admissions. This retrospective cohort study was carried out in 100 older (≥ 60 years) patients with polypharmacy and having two triggers from the triggerlist. The admissions were assessed as either possibly or unlikely medication-related according to the Assessment Tool for identifying Hospital Admissions Related to Medications. Of all the admissions 48% were classified as possibly medication-related. Patients with a possible medication-related hospital admission were more likely to have an impaired renal function (p = 0.015), but no differences with regard to age, sex, comorbidity or number of medicines were found. The high prevalence of medication-related hospital admissions, suggests the triggerlist may have added value as selection criterion in a cohort of older patients with polypharmacy and can be used to improve the identification of a population at high risk of medication-related hospital admissions.

Sections du résumé

BACKGROUND BACKGROUND
Of all hospital admissions in older patients, 10-30% seem to be medication-related. However, medication-related admissions are often unidentified in clinical practice. To increase the identification of medication-related hospital admissions in older patients a triggerlist is published in the Dutch guideline for polypharmacy.
AIM OBJECTIVE
To assess whether the triggerlist has value as selection criterion to identify patients at high risk of medication-related hospital admissions.
METHOD METHODS
This retrospective cohort study was carried out in 100 older (≥ 60 years) patients with polypharmacy and having two triggers from the triggerlist. The admissions were assessed as either possibly or unlikely medication-related according to the Assessment Tool for identifying Hospital Admissions Related to Medications.
RESULTS RESULTS
Of all the admissions 48% were classified as possibly medication-related. Patients with a possible medication-related hospital admission were more likely to have an impaired renal function (p = 0.015), but no differences with regard to age, sex, comorbidity or number of medicines were found.
CONCLUSION CONCLUSIONS
The high prevalence of medication-related hospital admissions, suggests the triggerlist may have added value as selection criterion in a cohort of older patients with polypharmacy and can be used to improve the identification of a population at high risk of medication-related hospital admissions.

Identifiants

pubmed: 36115001
doi: 10.1007/s11096-022-01447-y
pii: 10.1007/s11096-022-01447-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1205-1210

Subventions

Organisme : ZonMw
ID : 848016012
Pays : Netherlands
Organisme : ZonMw
ID : 848016012
Pays : Netherlands

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

van Marum RJ, Verduijn MM, de Vries-Moeselaar AC, et al. Polyfarmacie bij ouderen. Richtlijndatabase.nl. 2020. Cited 01 April 2022. https://richtlijnendatabase.nl/richtlijn/polyfarmacie_bij_ouderen/polyfarmacie_bij_ouderen_-_korte_beschrijving.html#tab-content-accountability . Accessed 1 Apr 2022.
Leendertse AJ, Egberts AC, Stoker LJ, HARM Study Group, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.
pubmed: 18809816
El Morabet N, Uitvlugt EB, van den Bemt BJF, et al. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66:602–8.
doi: 10.1111/jgs.15244 pubmed: 29468640
Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31:199–205.
doi: 10.1046/j.1445-5994.2001.00044.x pubmed: 11456032
McLachlan CY, Yi M, Ling A, et al. Adverse drug events are a major cause of acute medical admission. Intern Med J. 2014;44:633–8.
doi: 10.1111/imj.12455 pubmed: 24750276
Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017;73:759–70.
doi: 10.1007/s00228-017-2225-3 pubmed: 28251277
Kempen TGH, Hedström M, Olsson H, et al. Assessment tool for hospital admissions related to medications: development and validation in older patients. Int J Clin Pharm. 2019;41:198–206.
doi: 10.1007/s11096-018-0768-8 pubmed: 30585296
Linkens AEMJH, Milosevic V, van der Kuy PHM, et al. Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm. 2020;42:1243–51.
doi: 10.1007/s11096-020-01040-1 pubmed: 32472324 pmcid: 7522062
Leendertse AJ, Visser D, Egberts AC, et al. The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Saf. 2010;33:233–44.
doi: 10.2165/11319030-000000000-00000 pubmed: 20158287
Linkens AEMJH, Milosevic V, van Nie N, et al. Control in the hospital by extensive clinical rules for unplanned hospitalizations in older patients (CHECkUP); study design of a multicentre randomized study. BMC Geriatr. 2022;22:36.
doi: 10.1186/s12877-021-02723-8 pubmed: 35012478 pmcid: 8744034
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
doi: 10.1016/0021-9681(87)90171-8 pubmed: 3558716
van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf. 2008;17:365–71.
doi: 10.1002/pds.1565 pubmed: 18302300
Warlé-van Herwaarden MF, Valkhoff VE, Herings RM, et al. Quick assessment of drug-related admissions over time (QUADRAT study). Pharmacoepidemiol Drug Saf. 2015;24:495–503.
doi: 10.1002/pds.3747 pubmed: 25683383
Reijers EMC, van Strien AM, Derijks HJ, et al. Geneesmiddelgerelateerde SEH-bezoeken zonder opname bij ouderen. Nederlands Platform voor Farmaceutisch Onderzoek. 2021;6: a1734.
Saeed D, Carter G, Parsons C. Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies. Int J Clin Pharm. 2022;44:15–26.
doi: 10.1007/s11096-021-01354-8 pubmed: 34800255
Lea M, Mowe M, Mathiesen L, et al. Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward. PLoS ONE. 2019;14:e0220071.
doi: 10.1371/journal.pone.0220071 pubmed: 31329634 pmcid: 6645516
Zerah L, Henrard S, Thevelin S, et al. Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial [published correction appears in Age Ageing. 2022;51(3):]. Age Ageing. 2022;51:afab196.
doi: 10.1093/ageing/afab196 pubmed: 34794171
Coppes T, van der Kloes J, Dalleur O, et al. Identifying medication-related readmissions: two students using tools vs a multidisciplinary panel. Int J Clin Pract. 2021;75(11):e14768.
doi: 10.1111/ijcp.14768 pubmed: 34486783

Auteurs

A E M J H Linkens (AEMJH)

Department of Internal Medicine, Division of General Internal Medicine, Section Geriatric Medicine, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands. aimee.linkens@mumc.nl.
Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands. aimee.linkens@mumc.nl.

M J M Janssen (MJM)

Department of Internal Medicine, Zuyderland Medical Centre, Sittard, Geleen, The Netherlands.

N van Nie (N)

Department of Research, Innnovation and Funding, Zuyderland Medical Centre, Heerlen, Limburg, The Netherlands.

L Peeters (L)

General Pharmacist, Heerlen, The Netherlands.

B Winkens (B)

Department of Methodology and Statistics, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

V Milosevic (V)

Clinical Pharmacy, Elkerliek Hospital, Helmond, The Netherlands.

B Spaetgens (B)

Department of Internal Medicine, Division of General Internal Medicine, Section Geriatric Medicine, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
Department of Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.

K P G M Hurkens (KPGM)

Department of Internal Medicine, Geriatric Medicine, Zuyderland Medical Centre, Sittard, Geleen, The Netherlands.

P H M van der Kuy (PHM)

Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH